Reify Health funnels $220m into trial diversity effort
The clinical trial tech firm has announced a $220m Series D funding round which will boost its efforts to improve inclusivity and representation in studies.
Archives for May 10, 2022
AstraZeneca metastatic breast cancer treatment secures FDA approval
The US agency has approved Enhertu for patients diagnosed with HER2-positive metastatic breast cancer previously treated with an anti-HER2-based regimen.
Charles River, Valo join on AI-enabled drug discovery offering
The CRO has paired with the drug discovery technology firm on Logica, an artificial intelligence tool designed to accelerate development of new treatments.
FDA outlines benefit-risk approach to drug or biologic product quality assessment
The US FDA released new draft guidance yesterday discussing, among other challenges, how unresolved product quality issues might be addressed in the context of regulatory decision-making.